UNH240906P585000
- 4.15
- -0.45-9.78%
UnitedHealth Newsroom
UnitedHealth Price Target Maintained With a $591.00/Share by Cantor Fitzgerald
UnitedHealth Group Analyst Ratings
Mizuho Adjusts Price Target on UnitedHealth Group to $650 From $560, Maintains Outperform Rating
J.P. Morgan Remains a Buy on UnitedHealth (UNH)
JPMorgan Chase Adjusts Price Target on UnitedHealth to $652 From $559
Centene Downgraded at Jefferies Amid Higher Medicaid Utilization
Cantor Fitzgerald Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $591
UnitedHealth Group Analyst Ratings
Buy Rating on UnitedHealth Group: Proactive Management and Strong Growth Outlook
Deutsche Bank Raises Price Target on UnitedHealth Group to $632 From $562, Keeps Buy Rating
UnitedHealth Group Analyst Ratings
UBS Adjusts UnitedHealth Group Price Target to $680 From $640, Maintains Buy Rating
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
UnitedHealth's Strong Q2 Performance and Strategic Initiatives Secure Buy Rating
UnitedHealth (UNH) Gets a Buy From Cantor Fitzgerald
Jefferies Upgrades UnitedHealth to Buy, Cites Growth Outlook
Barclays Keeps Their Buy Rating on UnitedHealth (UNH)
Analysts Conflicted on These Healthcare Names: UnitedHealth (UNH) and Biogen (BIIB)
UnitedHealth Group Maintains Buy Rating: Sustainable Growth and Strategic Positioning Fuel Long-Term Trajectory
Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Veeva Systems (VEEV) and Arrowhead Pharmaceuticals (ARWR)